System and method for preventing gas leakage from intra-aortic balloon
The counterpulsation device addresses balloon leak and rupture issues by partially inflating an oversized balloon with an air mover and limiter, ensuring effective cardiovascular support and patient safety.
Patent Information
- Application Number
- JP2024081210
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-19
- Filing Date
- 2024-05-17
- Publication Date
- 2024-11-29
AI Technical Summary
Existing counterpulsation systems for heart failure treatment, such as intra-aortic balloon pumps (IABPs), face issues with balloon leaks and ruptures, leading to potential blood clots and strokes, and are limited in detecting leaks until gas has escaped, increasing patient risk.
A counterpulsation device with an oversized balloon that is partially inflated to prevent full expansion, using an air mover with an air movement limiter to control inflation, ensuring effective cardiovascular support without stress on the balloon and preventing gas leakage.
The device provides effective cardiovascular support while reducing balloon stress and preventing gas leakage, allowing for long-term ambulatory treatment of heart failure patients without the risks associated with full inflation.
Smart Images

Figure 2024167093000001_ABST
Abstract
Description
[Technical field]
[0001] The present technology relates to systems and devices for treating heart failure, and in particular to drive units configured to prevent leaks in intravascular circulatory assist systems. [Background technology]
[0002] The prevalence of heart failure is increasing worldwide and represents a costly burden for healthcare providers. Despite medical advances, the prognosis for patients with heart failure, especially those with advanced heart failure, remains poor. This is due in part to limited treatment options for such patients. Counterpulsation using an intravascular circular support system is a treatment option for heart failure. Such a system may include a thin, flexible tube called a catheter with a long, thin balloon attached to the tip of the catheter. The balloon is placed in the patient's aorta. The other end of the catheter may be attached to a computer console or "drive unit" that has mechanisms for inflating and deflating the balloon at the appropriate times during the heartbeat. The balloon acts as a balloon pump (i.e., an intra-aortic balloon pump (IABP)). The drive unit can inflate the balloon when the heart relaxes to push blood towards the end organs and coronary arteries to perfuse the heart. Also, before the left ventricle contracts, the drive unit can deflate the balloon to reduce the pressure the heart must pump. This allows the heart to pump more blood into the body while using less energy. The drive unit can keep the balloon inflated and deflated in sync with the heartbeat. One system that uses counterpulsation is described in U.S. Pat. No. 5,399,343 ("Heart Pump Augmentation System and Apparatus"), filed Jun. 4, 1963 by Watkins et al., which generally discloses an intra-aortic balloon pump (IABP) that uses reservoirs of high and low pressure air to inflate and deflate the balloon.
[0003] The drive unit can inflate and deflate the balloon with helium, air, or other gases or fluids. There are technical costs, patient usability and portability issues, and safety risks associated with the use of IABPs. For example, if the balloon leaks or ruptures, helium poses significant clot and stroke risks to the patient because it is not readily absorbed into the blood. To a lesser extent, systems that use air or other fluids present similar risks if the balloon leaks or ruptures.
[0004] Past IABP counterpulsation systems have generally accounted for complete balloon inflation and have been unable to detect partial balloon inflation. · US Patent No. 5,399,663 ("Safety Connector for Balloon Pump", filed May 14, 1971 by Rishton et al.) describes venting gas if the IABP should be overinflated. If the measured IABP pressure exceeds a limit, a valve external to the patient opens and releases gas to the atmosphere. US Patent No. 5,399,663 also describes that insufficient inflation of the IABP can result in thrombosis. · US Patent No. 5,339,633 ("Method and Apparatus for Driving an Intra-Aortic Balloon Pump", filed May 27, 1997 by Leschinsky et al.) describes a two-stage balloon inflation step. First, an external driver applies a brief period of increased gas pressure to the balloon to facilitate initial inflation, but then describes a second "stop" stage in which the positive gas pressure is reduced to "normal" inflation pressure to prevent over-pressurization of the balloon. · US Patent No. 5,399,963 ("Cardiovascular Support Control System," filed Nov. 18, 2002 by Freed et al.) generally represents a "partial cycle" limiting balloon inflation over several cardiac cycles to measure the patient's arterial pressure. A pressure sensor in the external driver can then measure the timing of the dicrotic notch during the patient's cardiac cycle. The external driver synchronizes the balloon inflation with the patient's dicrotic notch timing. After the "partial cycle" measurements are completed, the system alternates between full inflation and full deflation of the balloon. The '593 patent generally describes accommodating different balloon sizes by controlling the degree of balloon inflation. During the counterpulsation inflation step, the balloon is fully inflated.
[0005] Past systems have also been described as able to detect IABP leaks, but only after gas has escaped the balloon, significantly increasing the risk of harm to the patient. · US Patent No. 5,399,633 ("Circulatory Assisted Device with Motor Driven Gas Pump" filed Jan. 14, 1994 by Lewis et al.) generally describes a method for checking for leaks in a gas management subsystem, but only when the counterpulsation system is external to the patient. · U.S. Patent No. 5,393,633 ("Balloon Catheter Leak Detection Method and Apparatus," filed July 11, 2001 by Williams) and U.S. Patent No. 5,393,633 ("Cardiovascular Support Control System," filed November 18, 2002 by Freed et al.) generally describe leak detection by monitoring pressure over multiple counterpulsation cycles at the same point in the cycle. If the pressure drops beyond a preset threshold, air escapes and the system generates an alarm. The threshold must be large enough to minimize false alarms. A pressure drop may indicate a leak, but a leak does not, in itself, indicate whether the lost air has entered the patient's vascular system, entered inside the body but outside the vascular system, or leaked from a component external to the patient. Furthermore, because system pressure is typically not at a steady state during the counterpulsation cycle, this method can generate significant false alarms. · Patent Document 7 ("Leak Detector for an Intra-Aortic Balloon Pump", filed March 27, 1992 by Isoyama et al.) describes leak detection by monitoring the position of an isolation diaphragm within the system. · Patent document 8 ("Method and an Apparatus for Intra-Aortic Balloon Monitoring and Leak Detection", filed June 10, 1983 by Normann) describes leak detection by monitoring the electrical impedance of a counterpulsation device.
[0006] Thus, past counterpulsation systems have generally described that the balloon should be fully inflated or slightly over-inflated during its inflation phase. Past systems have believed this inflation method is desirable to maximize counterpulsation assistance. Past counterpulsation systems also identified a balloon leak only after air had escaped the balloon.
[0007] There is a significant need for a counterpulsation IABP device that is effective while only partially inflating the balloon, reducing stress on the balloon and preventing air from escaping if lift occurs in the balloon membrane. [Prior art documents] [Patent documents]
[0008] [Patent Document 1] U.S. Patent No. 3,266,487 [Patent Document 2] U.S. Patent No. 3,720,199 [Patent Document 3] U.S. Patent No. 5,817,001 [Patent Document 4] U.S. Patent No. 6,735,532 [Patent Document 5] U.S. Patent No. 5,513,956 [Patent Document 6] U.S. Patent No. 6,536,260 [Patent Document 7] U.S. Patent No. 5,242,374 [Patent Document 8] U.S. Patent No. 4,522,194 Summary of the Invention
[0009] A counterpulsation IABP device can avoid full balloon inflation to prevent a damaged or defective balloon from releasing gas into the aorta, yet still provide effective cardiovascular circulatory support. The device includes a balloon with a fully inflated volume that is greater than the effective counterpulsation volume for the patient. For example, a device for a patient requiring support provided by a fully inflated 50cc balloon (i.e., an effective counterpulsation volume of 50cc) may be configured with a balloon with a fully inflated volume greater than 50cc (e.g., 55cc or greater). A drive unit for the device may employ an air mover to deliver the effective counterpulsation volume (e.g., 50cc) into the oversized balloon. In some embodiments, the drive unit may employ an air mover, such as a bellows, compressed gas cylinder, compressor, pneumatic piston, diaphragm, or other mechanism, to deliver the effective counterpulsation volume into the oversized balloon. In all embodiments, the oversized balloon is underinflated. Under-inflation of the balloon provides effective cardiovascular circulatory support while avoiding stress on the balloon and preventing gas leakage if high cycle fatigue damages the balloon wall.
[0010] A system for limiting the expansion of an expandable member (e.g., a balloon) within an intravascular circulatory assist system of a patient may include a drive unit and an air mover limiter. The drive unit may include an air mover and a motor. The air mover may have a first end and a second end. The first end may be fixed and have an air pressure output in fluid communication with the expandable member. The second end may be movable and pneumatically closed. The air mover limiter may be configured to limit displacement of the second end to underinflate the expandable member based on the patient's blood pressure. Displacement of the second end moves a volume of air into and out of the expandable member. The volume of air corresponds to an air mover limiter configuration. [Brief description of the drawings]
[0011] Many aspects of the present technology can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure.
[0012] [Figure 1] 1 illustrates an example of an intravascular circulatory assist system implanted within a patient's vascular system. [Figure 2A] FIG. 1 shows a top external perspective view of a first exemplary embodiment of a drive unit for an intravascular circulatory assist system. [Figure 2B] FIG. 2B shows a top external view of the drive unit of FIG. 2A. [Figure 2C] 1 illustrates an exemplary mechanical limit for an air mover limiter. [Figure 2D] 1 illustrates an exemplary mechanical limit for an air mover limiter. [Diagram 3] FIG. 2 shows a top external perspective view of a second exemplary embodiment of a drive unit for an intravascular circulatory assist system. [Figure 4] FIG. 4 shows a block diagram of some control components applicable to the drive units of FIGS. 2A and 3. [Diagram 5] 1 shows a flow chart of an exemplary method for an air mover limiter. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0013] Specific details of some embodiments of the present technology are described below with reference to the drawings. Many of the embodiments are described below with respect to the use of an intravascular circulatory assist system / intravascular ventricular assist device ("iVAD"), which positions an IABP / balloon in the aorta to provide counterpulsation to help move blood through the body while preventing leakage due to balloon failure, but other applications and other embodiments are within the scope of the present technology in addition to those described herein. For example, some other embodiments of the present technology can have different configurations, components, or procedures than those described herein, and features of the illustrated embodiments can be combined with each other. Thus, one skilled in the art will understand that the present technology can have other embodiments with additional elements, or that the present technology can have other embodiments without some of the features illustrated and described below.
[0014] The terms used in the description presented below are intended to be interpreted in their broadest reasonable manner, even when used in conjunction with a detailed description of a particular embodiment of the present technology. Certain terms may be further emphasized below. However, any terms intended to be interpreted in any limited manner are clearly and specifically defined as such in this detailed description section. Furthermore, the present technology may include other embodiments that are within the scope of the examples but are not described in detail with respect to the drawings.
[0015] Throughout this specification, reference to "one embodiment" or "an embodiment" means that a particular feature, structure, or characteristic described in connection with an embodiment is included in at least one embodiment of the technology. Thus, the appearances of the phrases "in one embodiment" or "in an embodiment" in various places throughout this specification do not necessarily all refer to the same embodiment. Furthermore, particular features or characteristics may be combined in any suitable manner in one or more embodiments.
[0016] (Heart Failure and Circulatory Support Systems) Heart failure occurs when the heart can no longer maintain blood flow to meet the body's needs. This can occur when the heart fails to pump or fill with blood adequately during contraction and relaxation, respectively. Heart failure is a common, costly, and potentially fatal condition. For example, heart failure currently affects approximately 6.5 million patients in the United States and is expected to increase by 46% by 2030. The stage / severity of heart failure can be defined using the New York Heart Association (NYHA) class, with NYHA class I representing early stage disease and NYHA class IV representing late stage disease. Current treatment options for heart failure depend on the stage of heart failure and include, among other options, pharmacological therapy, cardiac resynchronization therapy (CRT), long-term mechanical circulatory support (e.g., left ventricular assist device, or "LVAD"), and heart transplantation. Pharmacological therapy and CRT are typically used in relatively early stage cases (e.g., in patients with NYHA class II or early NYHA class III heart failure). However, these therapies typically only slow the progression of heart failure, meaning that even patients who initially respond to pharmacological therapy or CRT typically experience disease progression and require more advanced therapeutic intervention.
[0017] The prognosis for patients with heart failure remains poor, with 1-year mortality rates of approximately 15.0% for NYHA class III patients and approximately 28.0% for NYHA class IV patients. This is due, at least in part, to the limited number of treatment options available for patients with late NYHA class III / early NYHA class IV heart failure. For example, heart transplantation offers the best chance for long-term survival in late NYHA class IV patients, but this option is limited due to a shortage of donor organs (e.g., approximately 2000 cases per year in the United States, 200 cases per year in Canada, and less than 100 cases per year in Japan). Thus, many NYHA class III and class IV patients must turn to other treatments. For example, some patients undergo LVAD therapy as a bridge to heart transplantation or as a stand-alone therapy. However, LVAD therapy has several inherent drawbacks that limit their widespread use. Current LVAD therapies are expensive (e.g., over $100,000), typically require extensive surgery to implant (typically a sternotomy or thoracotomy), typically require the use of cardiopulmonary bypass during the implantation procedure, and typically require blood products (e.g., about 11.6 units of blood products). LVAD therapies implanted by minimally invasive means (e.g., percutaneously) are only used for short-term circulatory support. In addition, postoperative care of patients receiving LVADs is difficult and expensive, and patient anxiety can be high because the device cannot be shut down or powered off for more than a few minutes. LVAD therapies are also associated with several serious adverse events, such as device failure, thrombosis, thromboembolism, stroke, infection, and hemorrhage. For at least these reasons, LVAD therapies are typically only applied to patients with end-stage heart failure (e.g., late NYHA class IV) who have limited options. This leaves the majority of patients with heart failure who are too advanced for CRT but not yet severe enough to justify LVAD therapy / heart transplant without effective treatment options (e.g., late NYHA class III / early NYHA class IV patients) without effective treatment options.Currently, there are approximately 1.6 million patients in the United States and 3.9 million patients in Europe with late class III / early class IV heart failure, representing a large patient population with limited treatment options.
[0018] Another treatment option for heart failure is counterpulsation therapy using an intra-aortic balloon pump (IABP). Counterpulsation therapy is achieved by rapidly inflating a balloon placed within the patient's aorta immediately after aortic valve closure (diachronic notch) and rapidly deflating the balloon just before the onset of systole. Rapid inflation of the balloon increases diastolic aortic pressure by 25-70%, enhancing end-organ and coronary perfusion. Rapid deflation of the balloon reduces native ventricular ejection pressure, reducing afterload and left ventricular external work.
[0019] Counterpulsation therapy is an attractive therapeutic option because using an IABP is much more convenient and has fewer adverse events than implanting and using an LVAD. For example, a physician can implant an IABP without directly cannulating the heart. However, conventional counterpulsation systems implanted by minimally invasive procedures can only be used for a short period of time. This is the case for several reasons. For example, issues with arterial access (e.g., femoral artery), IABPs, and in general, especially the durability and biocompatibility of the balloon, can limit the use of IABPs to a short duration of less than about 14 days. Longer durations of IABP support (>14 days) can lead to increased frequency of vascular complications, infections, balloon rupture, and bleeding. Furthermore, in its current form, a catheter-mounted IABP advanced retrogradely from the femoral artery into the descending aorta requires the patient to remain in a supine position for the duration of the treatment. As a result, the patient is unable to walk or leave the hospital. Due to these limitations, IABPs are not used for the long-term treatment of heart failure, but instead are used in short-term settings, such as patients awaiting transplants and those undergoing coronary artery bypass surgery.
[0020] The assignee / applicant (NuPulseCV, Inc.) has developed a variety of counterpulsation support systems designed to provide long-term support to patients suffering from heart failure as compared to the conventional systems discussed above. Such improved counterpulsation support systems are disclosed in U.S. Patent No. 7,892,162 ("ARTERIAL INTERFACE", filed October 22, 2009), U.S. Patent No. 8,066,628 ("INTRA-AORTIC BALLOON PUMP AND DRIVER", filed October 22, 2010), U.S. Patent Application No. 15 / 685,553 ("BLOOD PUMP ASSEMBLY AND METHOD OF USE THEREOF", filed August 24, 2017), U.S. Patent Application No. 16 / 876,110 ("INTRAVASCULARLY DELIVERED BLOOD PUMPS AND ASSOCIATED DEVICES, SYSTEMS, AND METHODS", filed May 17, 2020), U.S. Patent Application No. 17 / 944,130 ("INTRA-AORTIC BALLOON PUMP ASSEMBLY WITH No. 17 / 944,125 ("BLOOD PUMP SUPPORT APPARATUS AND METHOD FOR A BLOOD PUMP ASSEMBLY", filed September 13, 2022), U.S. Patent Application No. 17 / 944,127 ("INTRA-AORTIC BALLOON PUMP ASSEMBLY", filed September 13, 2022), and U.S. Patent Application No. 17 / 878,632 ("DRIVE UNIT FOR INTRAVASCULAR CIRCULATORY SUPPORT SYSTEMS", filed August 1, 2022), the entire disclosures of each of the foregoing are incorporated herein by reference.
[0021] The IABPs described in the incorporated disclosures provide long-term or chronic counterpulsation therapy for heart failure patients with components that, at least in certain instances, can be implanted using minimally invasive percutaneous procedures, e.g., the IABPs can be implanted minimally invasively without entering the chest and generally do not require cardiopulmonary bypass or administration of blood products.
[0022] The present technology provides a drive unit that can direct fluid (gas or liquid, e.g., air) into the interior volume of a balloon or expandable member (e.g., IABP, as described in the above-incorporated disclosures) implanted in a patient's vasculature to provide effective cardiovascular circulatory support while avoiding stress on the balloon and preventing gas leakage upon balloon rupture. The drive unit hardware and / or software controls the inflation / deflation cycle of the expandable member to prevent full inflation. This under-inflation avoids the formation of rifts in the expandable member due to high inflation / deflation cycle fatigue. Furthermore, even if rifts form in the membrane of the expandable member, this under-inflation does not allow gas to escape into the patient's vasculature.
[0023] (Selection of an embodiment of a chronic intravascular circulatory support system) FIG. 1 illustrates a circulatory and / or intravascular ventricular assist system 100 configured in accordance with selected embodiments of the present technology. The system 100 can include an expandable member 110 implantable in the aorta of a patient suffering from heart failure. The expandable member 110 may be referred to as an IABP or a balloon. The system 100 can further include a first pneumatic drive line 120 (also referred to as an "internal drive line"), an arterial interface device or stopper 130, a second pneumatic drive line 140, a skin interface device 190, a drive unit 150, and a sensor 160. When implanted, the system 100 can provide counterpulsation therapy to a patient suffering from heart failure.
[0024] The expandable member 110 can be a balloon or other element that can change size and / or shape in response to being filled with a gas or liquid. For example, in some embodiments, the expandable member 110 is a balloon constructed from a biocompatible, non-thrombogenic elastomeric material (e.g., Biospan®-S). The expandable member 110 can also be made from other suitable materials. The expandable member 110 is transitionable between at least a first state in which it is generally contracted and a second state in which it is generally inflated to an effective counterpulsation volume.
[0025] The effective counterpulsation volume may be the volume of fluid that occupies the expandable member 110 after rapid expansion of the expandable member 110 placed in the aorta of a patient immediately following closure of the aortic valve (dicrotic notch). The effective counterpulsation volume in the expandable member 110 increases the diastolic aortic pressure by 25-70%, enhancing end organ and coronary perfusion. The effective counterpulsation volume may be based on the minimum therapeutic diastolic blood pressure of a particular patient, or the average minimum therapeutic diastolic blood pressure of a patient population. The size of the expandable member 110 and / or air mover 220, 320 of the drive unit 200, 300 (FIGS. 2 and 3) is selected such that the effective counterpulsation volume is less than the fully expanded volume of the expandable member 110. For example, the effective counterpulsation volume of a patient may be 50 cc to achieve the minimum therapeutic diastolic blood pressure of the patient, or the average minimum therapeutic diastolic blood pressure of a patient population. To prevent excessive expansion stresses on the expandable member 110 and to prevent gas from leaking from a ruptured expandable member within the patient's vasculature, the expandable member 110 may include a fully inflated volume greater than 50 cc (e.g., 55 cc), while the air mover 220, 320 may be configured to expel a volume of air less than the fully inflated volume of the expandable member 110 (i.e., the patient's minimum therapeutic diastolic blood pressure, or the average minimum therapeutic diastolic blood pressure of a patient population). The "air mover" 220, 320 may include a bellows, compressed gas cylinder, pneumatic piston, diaphragm, compressor, or other mechanism for providing an effective counterpulsation volume to an oversized balloon. The bellows includes an air pressure output in fluid communication with the expandable member 110, a first end (e.g., static flange 229, 329 in FIGS. 2A, 2B, and 3) and a second end (e.g., dynamic flange 228, 328 in FIGS. 2A, 2B, and 3). The first end is fixed and the second end is displaceable. Although the embodiments of FIGS. 2A, 2B, and 3 describe an "air mover" as bellows 220, 320, this "air mover" is not limited to a bellows configuration and may include any mechanism for delivering an appropriate gas volume into the expandable member 110.
[0026] Full inflation of the expandable member 110 depends on various parameters of the system 100. For example, a "fully inflated" expandable member 110 may depend on the pneumatic system volume, the size or capacity of the expandable member 110, the change in volume of the bellows 220, 320 corresponding to the inflation and deflation cycles, and the patient's blood pressure. With the exception of the patient's blood pressure, these parameters may be measured or compiled from the system 100 and its components as described in connection with FIG. 1. Thus, the blood pressure threshold at which leakage may occur is the lowest therapeutic diastolic blood pressure for the patient. Given the pneumatic system, the expandable member volume, and the lower blood pressure threshold, the movement of the bellows 220, 320 is limited to prevent full inflation of the expandable member 110. As described herein, the limits on the bellows movement may be implemented mechanically or by software instructions.
[0027] Thus, the expandable member 110 can provide counterpulsation therapy without risk of the expandable member 110 bursting or leaking fluid into the patient's vasculature by repeatedly transitioning between a first state (contracted) and a second state (inflated) without exceeding the effective counterpulsation volume. To transition the expandable member 110 between the first and second states, the drive unit 150 can direct the effective counterpulsation volume of fluid (gas or liquid, e.g., air) to the interior volume of the expandable member 110 via the first pneumatic drive line 120 and the second pneumatic drive line 140, as described in more detail below. The expandable member 110 can also be sized and / or shaped such that the interior volume when fully expanded is less than the effective counterpulsation volume, reducing and / or preventing the expandable member 110 from blocking arteries branching from the aorta, such as the renal arteries. In some embodiments, the expandable member 110 may also have certain features generally similar to those described in the disclosures incorporated herein by reference. In some embodiments, the expandable member 110 includes an expandable end effector other than or in addition to a balloon.
[0028] The drive unit 150 can generate gas flow into and out of the expandable member 110 via the first pneumatic drive line 120 and the second pneumatic drive line 140, which converge to form an external pneumatic drive line 172 extending from the drive unit 150. For example, the drive unit 150 can generate a positive pressure to accelerate gas into the expandable member 110 via the first pneumatic drive line 120 and the second pneumatic drive line 140, thereby inflating the expandable member 110. The drive unit 150 can also induce a negative pressure to draw gas out of the expandable member 110 via the first pneumatic drive line 120 and the second pneumatic drive line 140, thereby deflating the expandable member 110. The drive unit 150 can induce gas flow into and out of the expandable member 110 through a bellows (not shown in FIG. 1 ). In some embodiments, the drive unit 150 can control the volume of air forced into the expandable member 110 to avoid the expandable member 110 from fully expanding or over-expanding. For example, in embodiments utilizing a bellows to generate the airflow, the volume of the airflow generated by the bellows (e.g., the volume of the bellows) can correspond to the patient's minimum therapeutic diastolic blood pressure, which is less than the internal volume of the expandable member 110, or the average minimum therapeutic diastolic blood pressure of a patient population. In other embodiments, the volume of fluid expelled by the bellows can be limited by an air mover limiter (not shown in FIG. 1 ) to reduce the capacity of the bellows to correspond to an effective counterpulsation volume that is also less than the internal volume of the expandable member 110. The air mover limiter can be mechanical, software instructions that control a mechanical component, or a combination of mechanical and software components. Those skilled in the art will recognize that the volume of the air mover can differ from the internal volume of the balloon due to changes in relative pressure. In some embodiments, the drive unit 150 uses ambient air from the environment surrounding the drive unit 150 (eg, “room air”) to power the operation of the system 100 .The use of ambient air is expected to reduce the size, weight, and / or cost of the drive unit 150 compared to drive units that rely on an internal gas or fluid supply (e.g., a helium tank). For example, in some embodiments, the drive unit 150 may weigh about 3 kg or less. The drive line may be disconnected near the skin interface device 190 when the system 100 is not actively in use.
[0029] System 100 may allow for continued support of cardiac function and blood flow while the patient remains ambulatory. Typical ventricular assist devices require femoral access for drive lines and / or connection to a large stationary external control unit, thus constraining the patient to a supine hospital bed for the duration of treatment. In contrast, system 100 allows the patient to move about relatively unhindered. Furthermore, the level of treatment provided by system 100 can be adjusted to suit the needs of the patient. For example, the effective counterpulsation volume and support ratio (e.g., 1:1, 1:2, 1:3 support) provided by expandable member 110 can be adjusted for each patient to vary the support provided while maintaining insufficient inflation of expandable member 110 to prevent excessive stress and / or gas leakage. One skilled in the art will recognize that the support ratio measures the ratio of pulsation to balloon inflation. For example, a support ratio of 1:1 indicates that for each beat there is a corresponding inflation of the balloon, a support ratio of 1:2 indicates that there are two beats before each inflation, and a support ratio of 1:3 indicates that there are three beats before each inflation.
[0030] The drive unit 150 may have a user interface (not shown) that allows a clinician to control the effective counterpulsation volume or support ratio. Alternatively, the drive unit 150 may be controlled via other external inputs (e.g., using a compatible tablet or other device in electronic communication with the drive unit 150). By gradually decreasing the effective counterpulsation volume over time (e.g., by changing the desired movement of the internal bellows mechanism as a percentage of the total movement), the loading of the heart may be controlled, which may be beneficial for cardiac recovery in some cases. Similarly, the movement of the internal bellows mechanism may be limited mechanically and / or by computer instructions via a user interface to limit the expansion volume of the expandable member 110 to less than the fully expanded volume. Furthermore, unlike conventional circulatory assist systems, the system 100 may be turned off to assess the patient's ability to cope with the demands of the heart without assistance, e.g., before removing the system 100, or for another suitable reason. In some embodiments, for example, the expandable member 110 is designed to remain in the aorta in a contracted state for a relatively long period of time (e.g., for 23 hours per day). This is in stark contrast to conventional devices, which often had to be removed if turned off for more than about 15 minutes, as reactivation could result in a large eruption of clots that had formed while in the inactive state.
[0031] (Drive unit) This disclosure contemplates at least two embodiments of the drive unit 150. A first embodiment is shown in Figures 2A-B and refers to the drive unit by reference numeral 200. A second embodiment is shown in Figure 3 and refers to the drive unit by reference numeral 300.
[0032] FIG. 2A shows a first embodiment of a drive unit 200. The drive unit 200 may include a bellows 220 and a motor 222 (e.g., an electric motor such as a brushless DC motor). The space to the left of the bellows 220 in FIG. 2A may be at least partially occupied by electrical components (not shown) used to control the motor 222. Such components may include one or more computer processors and memory containing computer processor-readable instructions executable by the computer processor. The same space may be at least partially occupied by mechanical components such as a value manifold (e.g., for coupling the bellows output / pneumatic output 223 to the applicable port 204).
[0033] Bellows 220 may be an axially expanding bellows and may expand and contract along axis AA depicted in FIG. 2A in response to rotation of motor 222 in different directions. In the embodiment depicted by FIG. 2A and 2B, bellows 220 is expanded such that expandable member 110 (FIG. 1) is contracted. When bellows 220 is compressed by motor 222, expandable member 110 (FIG. 1) expands. Bellows 220 may have a constant cross-sectional shape along its length such that the volume within bellows 220 varies along the length of the bellows.
[0034] Motor 222 may include rotor 222a and stator 222b. Rotor 222a may be joined to a rotary-to-linear converter. For example, rotor 222a may be joined to a ball nut 224 carrying a ball screw 226 affixed to a dynamic flange 228. Bellows 220 may be sealed by dynamic flange 228 at a second end of the bellows proximal to ball screw 226 and by static flange 229 (FIG. 2A) at a first end of the bellows distal to ball screw 226. Bellows outlet 233 (FIG. 2A) may allow communication of fluid in external drive line 172 to expandable member 110 in response to movement or displacement of the second end of the bellows (i.e., dynamic flange 228).
[0035] In some embodiments, bellows outlet 233 may be formed in static flange 229. Ball screw 226 may combine with ball nut 224 to form a mechanical rotary-to-linear converter that converts rotary motion of motor 222 into linear motion with little friction. Rotation of ball nut 224 by rotor 222a within stationary stator 222b may cause ball screw 226 to move linearly along axis AA, which may correspondingly cause linear movement of bellows 220.
[0036] The ball screw 226 may be threaded to provide a helical raceway 226a for the balls 226b (FIG. 2C) of the ball nut 224 and may act as a precision thread. Several dimensions may define the ball screw 226 and the raceway 226a. For example, the ball screw 226 may include a pitch that measures the distance between grooves of the helical raceway 226a.
[0037] The rotor 222a and ball nut 224 assembly may be mounted to a housing 230 of the motor 222 via a radial bearing 232. An inner ring of the radial bearing 232 may be affixed to the rotor 222a and ball nut 224 assembly, and an outer ring of the radial bearing 232 and the stator 222b may be affixed to the motor housing 230. When the motor 222 is actuated, the rotor 222a and ball nut 224 rotate, which causes the balls 226c (FIG. 2C) of the ball nut 224 to ride in the helical raceways 226a of the ball screw 226, converting the rotational motion of the rotor 222a into linear motion of the ball screw 226 along axis AA (FIG. 2A).
[0038] Movement of the ball screw 226 is transferred to the bellows 220 via the dynamic flange 228, causing the bellows 220 to expand or contract, respectively, generating a negative or positive fluid flow in the external drive line 172, which is in fluid communication with the expandable member 110 via the bellows outlet 233 (FIG. 2A). In some embodiments, the ball screw 226 may be fixedly mated to the dynamic flange 228 via a threaded interface (as depicted in FIG. 2B). In some embodiments, the dynamic flange 228 and the ball screw 228 are one continuous piece. When the ball screw 226 is fixedly mated to the dynamic flange 228, or when the ball screw 226 and the dynamic flange 228 are one continuous piece, the ball screw 228 can directly and efficiently translate its motion to the bellows (e.g., pulling the ball screw 226 away from the static flange 229 can pull the dynamic flange 228 to expand the bellows 220).
[0039] 2C-2D, in some embodiments, the ball nut 224 may be configured as an air mover limiter that mechanically limits the contraction of the bellows and positive fluid flow in the external drive line 172 such that the expandable member 110 is inflated to an effective counterpulsation volume but remains under-inflated. In some embodiments, the air mover limiter may be a ball nut 224 that includes a stop pin 224a. The air mover limiter may allow the ball nut 224 to rotate while limiting the movement of the bellows 220 along the ball screw 226 via the dynamic flange 228 by stopping further linear movement of the air mover limiter 224 along the axis AA. A clutch-like collar 240 on the inside of the air mover limiter 224 prevents the air mover limiter 224 from moving past the stop pin 224a. The stop pin 224a may be located in a valley or root of the track 226a (e.g., by drilling a hole and pressing in the stop pin). The stop pin 224a is positioned to limit the ball nut 224 from rotating along the ball screw 226 and insufficiently expanding the expandable member 110. When the collar 240 contacts the stop pin 224a, the air mover limiter 224 disengages from the track and begins to idle. In order for the air mover limiter 224 to begin moving again, the rotor 222a and the air mover limiter 224 assembly are rotated in the opposite direction. The air mover limiter may include other mechanical means to limit the movement of the bellows 220 or otherwise limit the expansion of the expandable member to less than its full expansion volume.
[0040] 2A-B and 4, the drive unit 200 may include a processor 402, a memory 404, and the drive unit 402. The processor 402 may include one or more dedicated or non-dedicated microprocessors, microcontrollers, sequencers, microsequencers, digital signal processors, processing engines, hardware accelerators, application specific circuits (ASICs), state machines, programmable logic arrays, any integrated circuits, discrete circuits, etc., capable of processing data or information, or any suitable combination thereof. The memory 404 may include any suitable capable non-volatile memory device, chip, or storage device, such as one or more of a system memory, a frame buffer memory, a flash memory, a random access memory (RAM), a read only memory (ROM), a register, and a latch. The processor 402 may execute executable instructions (e.g., stored in the memory 404). The processor 402 may be configured to control the motor 222 and thus the bellows 220.
[0041] For example, the encoder disk 234 and the encoder sensor 236 may determine the angular position, speed, and / or direction of the rotor and provide such information as a position feedback signal to the processor 402 and / or memory 404. The encoder disk 234 is a component of an encoder that includes the encoder sensor 236. In combination with the encoder sensor 236, the encoder disk 234 converts mechanical motion into an electrical signal. The encoder disk is typically made of metal, plastic, glass, or paper and has a series of segments. The encoder sensor 236 can distinguish between the segments to determine disk rotation. In some embodiments, the segments are transparent and opaque, magnetic and non-magnetic, white and black, or any other series of alternating materials or appearances. Rotation of the disk 234 through the sensor 236 generates a series of electrical pulses that can be used to measure the speed, position, or direction of the encoder disk's rotation and, therefore, the motor 222's rotation.
[0042] The encoder disk 234 may also include a "home" position. The home position of the encoder disk is the position where the encoder points to the "zero value" or default position of the encoder when the encoder is turned on or reset. An incremental encoder disk may determine the home position by detecting the start of a pattern on the disk. For example, the disk 234 may have a pattern of alternating black and white lines. The encoder begins counting when it detects the first black line. An absolute encoder disk may determine the home position by reading a code value on the disk. For example, the disk may have a code that represents the number 0. The processor 402 and / or memory 404 (FIG. 4) may execute instructions to receive the code from the sensor 236, 336 (FIGS. 2 and 3) and store the code in the memory 404. The encoder sensor 236 may read the code and then set the position of the encoder disk 234 to 0. The home position may be important for a variety of reasons, such as measuring the rotation of the ball screw 228 and converting that movement into the volume of gas in the bellows 220 or gas released thereby, or aligning the encoder with another device. Once the home position is set, the processor 402 may execute instructions to return to that position when the encoder disk 234 is turned off or reset. This ensures that the encoder is always in the correct position.
[0043] Alternatively, a linear position sensor (not shown) may be used to determine the position of the ball screw 226 or the bellows 220 and provide such position feedback signal. The processor 402 and / or memory 404 may also receive control information from the drive unit UI 406 and provide display information (e.g., status information) to the drive unit UI 406. Relatedly, the processor 402 and / or memory 404 may also receive EKG signals from the skin interface device 190 and one or more sensors 160 (FIG. 1), one or more external control signals (e.g., from a tablet or other computing device (not shown)), and one or more sensor signals. For example, the processor 402 and / or memory 404 may receive a pressure signal as observed by a pressure sensor (not shown) positioned proximate to the balloon 110 when positioned within an artery (e.g., the descending aorta as depicted in FIG. 1) of a patient receiving treatment (e.g., counterpulsation treatment). The one or more pressure signals may be indicative of the pressure exerted on the balloon 110 within such artery and / or the pressure within such artery.
[0044] The processor 402 may use one or more of the position feedback signal, the drive unit UI 406 control signal, the EKG signal, the external control signal, and the sensor signal to control the motor 222. For example, the EKG signal may be used to ensure proper timing of inflation and / or deflation of the balloon 110 (e.g., to pursue counterpulsation), and the drive unit UI 406 control signal and the external control signal may be used to vary the effective counterpulsation volume, support ratio, and maximum inflation volume, as described above.
[0045] The various signals described above can monitor the patient's blood pressure to determine when it falls below the patient's minimum therapeutic diastolic pressure, or the average minimum therapeutic diastolic pressure for a patient population. This determination signals whether the expandable member 110 is fully inflated or over-inflated, and is used to further adjust the bellows displacement below a previously determined volume to keep the expandable member under-inflated. The bellows pressure profile during the inflation dwell or the patient's blood pressure during a partial cycle, or some combination of these measurements, may be used to signal full inflation or over-inflation.
[0046] Additionally, insufficient inflation of the expandable member 110 can be useful in detecting rupture of the expandable member 110. For example, because the pressure from insufficient inflation is never higher than the minimum diastolic pressure, blood may enter the pneumatic system through cracks or lifts in the expandable member 110 that may develop due to high cycle fatigue and steadily grow in size over time with continued use. Blood leaking through a crack or lift becomes visible in the pneumatic drive line. Insufficient inflation allows blood to enter, but if the lift is small, the air cannot exit. Observation of blood in the drive line indicates the need to discontinue support.
[0047] In other embodiments, the bellows 220 may be compressed and expanded using a linear brushless DC motor, a solenoid, and / or a piezoelectric actuator.
[0048] Drive unit 200 may be used to effectively inflate and deflate inflatable member 110 using ambient air to provide counterpulsation therapy to a patient with heart failure. The following component values set forth in the table below are exemplary for such purposes for counterpulsation using drive unit 200 and an approximately 20-60 cc balloon as inflatable member 110. [Table 1]
[0049] While generally effective for counterpulsation, the drive unit 200 configured above uses a significant amount of power just to overcome the rotational inertia of the rotor 222a and may not be "fast" enough to treat patients with cardiac arrhythmias, irregular heartbeats, or a-fib. The ball screw pitch may be selected or adjusted to improve the efficiency of the drive unit. In particular, by adjusting the ball screw pitch (and / or adjusting the diameter of the bellows 220), the impedance of the motor 222 may be better matched to the impedance of the pneumatic load on the drive unit 200 (e.g., the collective pneumatic load of the balloon 110, the first pneumatic drive line 120, the second pneumatic drive line 140, and the external drive line 172). Such improvements in efficiency may improve the battery life of any batteries used to drive the motor 222.
[0050] 3, a second embodiment of the drive unit 300 may include a bellows 320 and a motor 322 (e.g., an electric motor such as a brushless DC motor). The bellows 320 may be an axially expanding bellows and may expand and contract along a B-B axis depicted in FIG. 3 in response to rotation of the motor 322 in different directions. As shown in FIG. 3, the bellows 320 may include a dynamic flange 328. The dynamic flange 328 may be sized and shaped to receive or accommodate at least a portion of the motor 322 such that at least a portion of the motor 322 is nested within the bellows cavity 320a. For example, the direction of the recess 328a may be toward the bellows cavity 320 and may take a suitable three-dimensional shape (e.g., a cylinder) to receive or accommodate and nest at least a portion of the motor 322 within the bellows cavity 321a while maintaining a sufficient stroke length to provide effective airflow within the external drive line 172. Recess 328a may allow for a reduction in size and weight of outer case 302, which may also improve mobility of the system (e.g., as compared to the size of outer case 202). In the embodiment depicted in Figure 3, bellows 320 is depicted in an expanded or uncompressed state such that expandable member 110 (Figure 1) is contracted.
[0051] The motor 322 includes a rotor 322a and a stator 322b. As with the first embodiment 200, the rotor 322a may be molded to mate with a rotary-to-linear converter, such as a ball nut 324 carrying a ball screw 326 that is affixed to a dynamic flange 328 via a threaded interface. In other embodiments, the rotor 323 and ball nut 324 may be formed as a single piece. In some embodiments, the ball screw 326 is hollow to reduce weight. The rotor 323 and ball nut 324 assembly may be mounted to a housing of the motor 332 via a radial bearing 330. An inner ring of the radial bearing 330 may be affixed to the rotor 323 and ball nut 324 assembly, and an outer ring of the radial bearing 330 and the stator 323b may be affixed to the motor housing 332. As with the first embodiment, when the motor 322 is actuated, the rotor 323 and ball nut 324 may rotate, which may translate into linear motion of the ball screw 326 along axis BB. Movement of ball screw 326 is transferred to bellows 320 via dynamic flange 328, causing bellows 320 to expand or contract, producing negative or positive fluid flow, respectively, in external drive line 172, which is in fluid communication with expandable member 110 via bellows / pneumatic output 333 associated with static flange 329. In other embodiments, linear brushless DC motors, solenoids, and / or piezoelectric actuators may be used to compress and expand bellows 320.
[0052] The ball screw 326 may be fitted to the dynamic flange 328 (or the two components may be one continuous piece) so that while the rotor 322a and ball nut 324 rotate within the stator 322b about the axis BB, the ball screw 328 can directly and efficiently translate its motion to the bellows 320. Rotation of the rotor 322a can carry the balls of the ball nut 324 within the helical track 226a of the ball screw 226, thus causing movement of the ball screw 226 along the axis BB. In some embodiments, the ball nut 324 may be configured as an air mover limiter 224, as described in connection with FIGS. 2C-2D, to limit movement or displacement of the dynamic flange 328 and positive fluid flow within the external drive line 172, such that the expandable member 110 is expanded to an effective counterpulsation volume, but remains underexpanded.
[0053] 3 and 4, the encoder disk 334 and the encoder sensor 336 may determine the angular position, speed, and / or direction of the rotor and provide such information to a processor via an electrical feedback signal (not shown). The encoder disk 334 is a component of an encoder that includes the encoder sensor 336 and includes the same advantages as described above with respect to the encoder disk 234 and the encoder sensor 236. In other embodiments, a linear position sensor (not shown) may be used to determine the position of the ball screw 326 or the bellows 320 and provide that information to such a processor. Such a processor may also receive EKG signals from the skin interface device 190 and one or more sensors 160 (FIG. 1), suitable external control signals (e.g., from a tablet (not shown) configured to control the movement of the motor 322 and the bellows 220, a user interface (not shown) operably coupled to the case 302, etc.), and other sensors (e.g., a pressure sensor (not shown) capable of sensing pressure in the descending aorta).
[0054] The drive unit 300 may be used to effectively inflate and deflate the expandable member 110 using ambient air to provide counterpulsation therapy to patients with heart failure (including patients with cardiac arrhythmia, irregular heartbeat, or a-fib). The following ranges of component values may be efficient and / or economical for counterpulsation using the drive unit 300 and an approximately 20-60 cc balloon as the expandable member 110. [Table 2]
[0055] 4, the drive unit 200, 300 may include a processor 402, a memory 404, and a drive unit 402. The encoder disk 234, 334 and the encoder sensor 236, 336 may determine the angular position, speed, and / or orientation of the rotor and provide such information as a position feedback signal to the processor 402 and / or memory 404. In other embodiments, a linear position sensor (not shown) may be used to determine the position of the ball screw 226, 326 or the bellows 220, 320 and provide such a position feedback signal. The processor 402 and / or memory 404 may also receive control information from the drive unit UI 406 and provide display information (e.g., status information) to the drive unit UI 406. Relatedly, the processor 402 and / or memory 404 may also receive EKG signals from the skin interface device 190 and one or more sensors 160 (FIG. 1), one or more external control signals (e.g., from a tablet or other computing device (not shown)), and one or more sensor signals. For example, the processor 402 and / or memory 404 may receive a pressure signal as observed by a pressure sensor (not shown) positioned proximate to the balloon 110 when positioned within an artery (e.g., the descending aorta as depicted in FIG. 1) of a patient receiving treatment (e.g., counterpulsation treatment). The one or more pressure signals may be indicative of the pressure exerted on the balloon 110 within such artery and / or the pressure within such artery.
[0056] The processor 402 may use one or more of the position feedback signal, the drive unit UI 406 control signal, the EKG signal, the external control signal, and the sensor signal to control the motor. For example, the EKG signal may be used to ensure proper timing of inflation and / or deflation of the balloon 110 (e.g., to pursue counterpulsation), and the drive unit UI 406 control signal and the external control signal may be used to vary the effective counterpulsation volume, support ratio, and maximum inflation volume, as described above.
[0057] 5 is a software flow chart including processor executable instructions for a method 500 for initializing the drive unit 200, 300 for counterpulsation assistance with the objective of achieving a minimum therapeutic diastolic blood pressure for a patient, or an average minimum therapeutic diastolic blood pressure for a patient population. Each step of the method 500 is one or more processor executable instructions executed on a microprocessor or other computing device (e.g., the drive unit 200, 300 including a processor 402 and memory 404) that may be physically configured to perform different aspects of the method. Each step may include the execution of any of the instructions described in connection with the drive unit 200, 300. Although the following blocks are presented as an ordered set, the various steps described may be performed in any particular order to complete the air mover limiter method described herein.
[0058] In block 502, the processor 402 may execute a "power on" or "start up" command. For example, the processor executable instructions stored in the memory 404 may cause the processor 402 to begin an initialization sequence for the drive units 200, 300. In block 503, the processor may execute a "gas block" command to prevent gas from being forced into the bellows 220, 320 during execution of the method 500. For example, the block 503 may include the processor executing a command to configure (i.e., open or close) one or more valves in the system 100 to prevent gas from being forced into the bellows 220, 320. In block 504, the processor 402 may execute a "moving bellows" command. The processor executable instructions stored in the memory 404 may cause the processor 402 to provide power to the motors 222, 322 to move the bellows 220, 320. For example, the dynamic flanges 228, 328 may begin to move toward the static flanges 229, 329. In block 506, the processor 402 may execute a "check motor current" command. For example, the processor executable instructions stored in the memory 404 may cause the processor 402 to determine the current of the motor 222, 322. If the current is steady-state (i.e., does not rise above a threshold rate over time) or does not increase above a threshold amount, the method 500 may return to block 504 and continue the bellows movement. If the current rate increases or if the current itself exceeds the threshold, the method 500 may proceed to block 508. In block 508, the processor 402 may execute a "return bellows" command. The distance of this return movement may be a constant stored in memory. For example, the processor executable instructions stored in the memory 404 may cause the processor 402 to reverse the motor 222, 322 to a "home" position based on the read pulses from the encoder disk 234, 334. The distance between full compression and "home" also corresponds to the effective counterpulsation volume, as described herein. Finally, in block 510, the air valve is closed in preparation for counterpulsation pumping to assist the patient.
[0059] Assuming that drive unit 200 and drive unit 300 are configured to move the same amount of air when the corresponding bellows 220, 320 undergo linear motion from an expanded position to a contracted position or vice versa (i.e., to deflate or inflate the same sized balloon to an effective counterpulsation volume), drive unit 300 may have several advantages over drive unit 200. For example, drive unit 300 may be configured to be smaller and lighter (i.e., have a smaller volumetric enclosure) than drive unit 200, which may have a significant impact on the ability of a person who must carry drive unit 150 to move / engage in more ambulatory activities. In particular, bellows 320 may provide a smaller bellows travel distance (and a shorter ball screw) than drive unit 220. By increasing the bellows diameter in drive unit 300 relative to the bellows diameter in drive unit 200, (1) the impedance of the pneumatic load on the drive unit (e.g., the collective pneumatic load of balloon 110, first pneumatic drive line 120, second pneumatic drive line 140, and external drive line 172) is better matched to the impedance of the motor (i.e., the mechanical subsystem of the drive unit) and (2) the power consumption required for inflation and deflation is reduced, thereby increasing the efficiency of drive unit 300 compared to drive unit 200.
[0060] In such a configuration, the overall dimension of the drive unit 300 along the axis of linear motion (i.e., axis BB) can be smaller than the overall dimension of the drive unit 200 along the axis of linear motion (i.e., axis BB). The longest dimension of the drive unit 200 may be along its axis of linear motion (i.e., axis BB), but the longest dimension of the drive unit 300 may be orthogonal to its axis of linear motion (i.e., orthogonal to axis BB). This may be particularly true when both outer cases 202 and 302 are rectangular (or substantially rectangular in shape) and are configured such that the plane of the static flanges 229, 329 is parallel to the plane of the outer cases 202, 302. As shown in FIG. 3E, the longest dimension of the drive unit 300 may correspond to an axis parallel to the diameter of the bellows 320.
[0061] Additionally, the design of the drive unit 300 can be configured to operate fast enough to deflate the corresponding balloon or expandable member 110 by 50% within about 100 ms of the R wave in the QRS complex, thereby treating patients with irregular heartbeats (e.g., patients with atrial fibrillation or "a-fib"). As discussed above, a-fib is an irregular and / or rapid heart rate that occurs when the two upper chambers of the heart experience disorganized electrical signals. This results in a rapid and irregular heart rhythm that is difficult to predict for effective inflation and deflation of the expandable member 110. To effectively treat a-fib patients, the expandable member 110 should be deflated by at least 50% within about 100-120 ms of the R wave. Without the rapid deflation, the expandable member 110 may impede blood flow in the aorta and increase the workload of the heart. Using the R wave in the QRS complex as an indicator of ventricular contraction requires processing of the EKG signal to locate the R wave, which may consume approximately 20-50 ms depending on the algorithm employed using conventional and processor based algorithms. By setting the ball screw pitch in the drive unit 300 to 3.5-5.5 mm and using a bellows 320 with an outer diameter of 125-111 mm and an effective bellows travel distance of 8.0-11.5 mm, the drive unit 300 can effectively treat patients with irregular heartbeat and a-fib.
[0062] Additionally, drive unit 300 may be much more efficient than drive unit 200 with respect to power consumption, thereby extending the battery life of a battery (not shown) powering motor 322 as compared to a battery (not shown) powering motor 222, assuming the same such battery is the same. In particular, motor 222 may inefficiently use a disproportionate amount of power to overcome the rotational inertia of rotor 222a in drive unit 200 as compared to the amount of power utilized in drive unit 300 to overcome the rotational inertia of rotor 322a. Drive unit 300 achieves this advantage by (a) setting the ball screw pitch in drive unit 300 such that the impedance of motor 322 is the same or substantially the same (i.e., matched or substantially matched) as the impedance of the pneumatic load on drive unit 300, and / or (b) using an enlarged bellows 320, which allows for a design with reduced bellows travel (and may further help match or substantially match the impedance of motor 322 to the pneumatic load on drive unit 300).
[0063] The tables provided above for drive unit 200 and drive unit 300 are merely examples. Drive units having different component values are also contemplated as being within the scope of this disclosure.
[0064] (Conclusion) The above detailed description of the embodiments of the present technology is not intended to be exhaustive or to limit the present technology to the precise form disclosed above. Although specific embodiments of the present technology and examples thereof have been described above for illustrative purposes, various equivalent modifications are possible within the scope of the present technology, as will be recognized by those skilled in the art. Various embodiments described herein can also be combined to provide further embodiments.
[0065] Unless the context clearly requires otherwise, throughout the description and examples, words such as "comprise", "comprising" and the like should be construed in an inclusive sense, i.e., meaning "including, but not limited to", as opposed to an exclusive or exhaustive sense. As used herein, the terms "connected", "coupled", or any variation thereof, mean any connection or coupling, either direct or indirect, between two or more elements, and the coupling of connections between those elements may be physical, logical, or a combination thereof. In addition, as used in this application, the terms "herein", "above", "below", and terms of similar import shall refer to this application as a whole and not to any particular portions of this application. Where the context permits, terms in the above Detailed Description using the singular or plural may also include the plural or singular, respectively. As used herein, the phrase "and / or", such as in "A and / or B", refers to A alone, B alone, and A and B in combination. It will also be understood that, although certain embodiments have been described herein for illustrative purposes, various modifications may be made without departing from the technology. Moreover, while advantages associated with some embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments necessarily exhibit such advantages to fall within the scope of the technology. Thus, the present disclosure and related technology may encompass other embodiments not expressly depicted or described herein.
Claims
1. 1. A system for limiting expansion of an expandable member in an intravascular circulatory assist system of a patient, the system comprising: a drive unit including an air mover and a motor, the air mover having a pneumatic output in fluid communication with the expandable member, a first end, and a second end, the first end being fixed and the second end being displaceable; an air mover limiter configured to limit displacement of the second end to underinflate the expandable member based on a blood pressure of the patient; Equipped with Displacement of the second end moves a volume of air into and out of the expandable member, the volume of air corresponding to a configuration of the air mover limiter.
2. The system of claim 1 , wherein the interior volume of the expandable member is greater than the volume of air.
3. The system of claim 1 , wherein the patient's blood pressure comprises a minimum therapeutic diastolic blood pressure of the patient.
4. The system of claim 3 , wherein the first pressure corresponds to an effective counterpulsation volume based on the minimum therapeutic diastolic blood pressure of the patient.
5. The motor includes a rotor and a stator. a ball nut carrying a ball screw, the ball nut being fixed to the rotor, the ball screw including a helical raceway; The system of claim 1 .
6. the second end is defined by a dynamic flange configured to receive the ball screw; the ball nut includes a plurality of balls that ride in the helical raceway such that rotation of the rotor causes the plurality of balls to translate such rotation into linear motion of the ball screw within the ball nut, and the second end is fixed to the ball screw. The system of claim 5.
7. The system of claim 6 , wherein the air mover limiter comprises one or more of processor executable instructions for limiting an output of the air mover and a mechanical limit for limiting the output of the air mover.
8. 8. The system of claim 7, wherein the mechanical limit includes a clutch-like collar shaped to receive a stop pin during rotation of the ball nut in a first direction about the ball screw and to slide under a stop pin during rotation of the ball nut in a second direction about the ball screw.
9. 8. The system of claim 7, wherein the one or more processor-executable instructions for limiting the power output of the air mover include accessing a home position of an encoder disk coupled to the motor, the home position being stored in a processor-accessible memory.
10. 5. The system of claim 4, wherein the drive unit includes an encoder disk and an encoder sensor configured to determine one or more of an angular position, a speed, and an orientation of the rotor and to generate one or more position feedback signals based on the determined one or more of the angular position, the speed, and the orientation of the rotor.
11. The system of claim 10 , wherein the air mover limiter includes a processor configured to limit displacement of the second end further based on the one or more position feedback signals.
12. 12. The system of claim 11, wherein the processor is further configured to control the motor based on one or more EKG signals, the one or more EKG signals being of a patient receiving treatment, and one or more pressure signals being related to pressure in an artery of the patient.
13. The system of claim 1 , wherein the processor is further configured to control the motor based on one or more EKG signals, the one or more EKG signals being of a patient receiving treatment.
14. the bellows has an outer diameter; 5. The system of claim 4, wherein the outer diameter of the bellows is selected such that the drive unit can deflate the expandable member 50% within about 100-120 ms of receiving an R wave in a QRS complex detected in one or more EKG signals, the one or more EKG signals being of a patient receiving treatment.
15. The system of claim 14, wherein the outer diameter of the bellows is within a range of approximately 111 mm to 125 mm.
16. The system of claim 1 , wherein the distance traveled by the bellows is based on the selected outer diameter and effective counterpulsation volume of the bellows.
17. 17. The system of claim 16, wherein the effective counterpulsation volume is based on the minimum therapeutic diastolic blood pressure of a particular patient or the average minimum therapeutic diastolic blood pressure of a patient population.
18. 6. A system unit as claimed in claim 5, wherein the pitch of the helical track is selected such that the impedance of the motor is the same or substantially the same as the impedance of a pneumatic load on the drive unit.
19. 2. A system unit as claimed in claim 1, wherein the diameter of the bellows is selected so that the impedance of the motor is the same or substantially the same as the impedance of a pneumatic load on the drive unit.
20. The system of claim 5 , wherein the pitch of the helical track is in the range of approximately 3.5 mm to 5.5 mm.
Citation Information
Patent Citations
Heart pump augmentation system and apparatus
US3266487A
Safety connector for balloon pump
US3720199A
Method and an apparatus for intra-aortic balloon monitoring and leak detection
US4522194A
Leak detector for an intra-aortic balloon pump
US5242374A
Circulatory assisted device with motor driven gas pump
US5513956A
